Pancreatic Cancer Research

ResearcherMonash HealthActive in the last 2 years

Gregory Thomas Moore

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3689-8858; OpenAlex author ID A5088281977. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 2

  1. Handgrip Strength Predicts Survival in Patients With Pancreatic Cancer. Co-author DOI 10.1097/mpa.0000000000002319↗
  2. Body Composition Adjusted Dosing of Gemcitabine-Nab-Paclitaxel in Pancreatic Cancer Does Not Predict Toxicity Compared to Body Surface Area Dosing. Last author DOI 10.1080/01635581.2018.1542011↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Julia Freckelton · 2 shared papers, 2019–2024 · strength 0.42
  2. Daniel Gerald Croagh · 2 shared papers, 2019–2024 · strength 0.42
  3. Ashray Rajagopalan · 1 shared paper, 2024 · strength 0.31
  4. Adrian M. Fox · 1 shared paper, 2019 · strength 0.11
  5. Margaret Lee · 1 shared paper, 2019 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.